374
Participants
Start Date
January 31, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Moxifloxacin (Avelox, BAY12-8039)
Moxifloxacin - 400 mg once a day for 5 days
Placebo
Placebo - 380 mg Microcrystalline Cellulose
Rochester
Palmyra
Levittown
Norristown
Tappahannock
Raleigh
Charlotte
Atlanta
Warner Robins
Warner Robbins
Hialeah
Pembroke Pines
North Miami Beach
Plantation
Dunnellon
Birmingham
Northport
Clarksville
Louisville
Cincinnati
Dayton
Livonia
Detroit
Portage
Greenfield
Butte
Little Rock
Jonesboro
Houston
College Station
San Antonio
Austin
El Paso
Colorado Springs
West Jordan
West Jordan
Salt Lake City
Salt Lake City
San Diego
Garden Grove
Orange
San Luis Obispo
Fresno
Fresno
Roseville
Eugene
Bellingham
Bridgeport
Elizabeth
Lawrenceville
Somerville
Lead Sponsor
Bayer
INDUSTRY